Skip to main content

InflaRx N.V.

IFRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001708688

No open-market purchases or sales by InflaRx N.V. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $211.6M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding InflaRx N.V. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of IFRX: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders3127−4
Shares17.5M16.8M−708.9K (−4.0%)
Value$17.9M$13.3M−$4.59M (−25.7%)

New holders (9)

Institutions that held InflaRx N.V. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to IFRX in Q2 2025
InstitutionSharesValue% of portfolio
Ra Capital Management, L.P.1,973,233$1.56M0.03%
Ikarian Capital, LLC705,010$557.0K0.18%
Adage Capital Partners GP, L.L.C.331,113$261.6K0.00%
Concurrent Investment Advisors, LLC82,651$65.3K0.00%
Virtu Financial LLC60,415$48.0K0.00%
Gsa Capital Partners LLP57,951$46.0K0.00%
Simplex Trading, LLC25,712$20.0K0.00%
CIBC World Markets Inc.25,000$19.8K0.00%
UBS Group AG8,095$6.39K0.00%

Sold out (13)

Institutions that held InflaRx N.V. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of IFRX in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Silverarc Capital Management, LLC1,161,567$1.18M
StemPoint Capital LP725,019$739.5K
Northern Trust Corp618,903$631.3K
Citadel Advisors LLC432,822$441.5K
Franklin Street Advisors Inc75,100$77.0K
XTX Topco Ltd37,528$38.3K
Cubist Systematic Strategies, LLC30,053$30.7K
Quadrature Capital Ltd13,858$14.4K
Alyeska Investment Group, L.P.13,538$13.8K
Wells Fargo & Company2,000$2.04K
Steward Partners Investment Advisory, LLC550$561
Deutsche Bank AG200$204
Stonebridge Financial Group, LLC35$36